3-hydroxy-3-methylglutaryl-coenzyme a and Carcinogenesis

3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Carcinogenesis in 2 studies

*Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, Y; Wang, Z; Zhao, L; Zhou, C1
Bai, R; Bode, AM; Chang, X; Dong, Z; Li, X; Liu, K; Ma, W; Ryu, J; Song, Y; Wang, K; Wang, Q; Wang, T; Xia, Q; Zhang, T1

Other Studies

2 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Carcinogenesis

ArticleYear
Pan-cancer analysis reveals the oncogenic role of 3-hydroxy-3-methylglutaryl-CoA synthase 1.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:9

    Topics: Acyl Coenzyme A; Carcinogenesis; Cell Line, Tumor; Humans; Hydroxymethylglutaryl-CoA Synthase; Proteomics

2022
Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non-Small Cell Lung Carcinogenesis.
    Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:12

    Topics: Acyl Coenzyme A; Adult; Aged; Animals; Apoptosis; Carcinogenesis; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluvastatin; Gene Knockdown Techniques; HEK293 Cells; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Lung Neoplasms; Male; Mevalonic Acid; Mice; Middle Aged; Neoplasms, Experimental; Nitrosamines; RNA, Small Interfering; Xenograft Model Antitumor Assays

2019